Literature DB >> 6595454

Serum retinol and risk of subsequent cancer: extension of the Evans County, Georgia, study.

I Peleg, S Heyden, M Knowles, C G Hames.   

Abstract

A previous report from the Evans County, Ga., cohort correlated low base-line retinol levels in 1960-62 to an increased risk of cancer developing in the following 12-14 years. So that this inverse association could be retested, retinol determinations were performed on sera in 135 incident cancer cases, identified during a vital status follow-up in 1981, and in 237 controls matched by race, sex, age, and date of venipuncture. The serum was drawn during the second cohort examination between 1967 and 1969 and stored at -20 degrees C until analysis by high-pressure liquid chromatography in January 1982. Eligible for the study were patients whose initial cancer diagnosis was established more than 24 months after venipuncture. Base-line retinol levels of subsequent cancer cases and their matched controls were similar in the 4 race-sex groups. The risk of cancer at all sites associated with the lowest retinol quintile was similar to that associated with the highest quintile. In multivariate analysis, with control for age, cholesterol, body mass, smoking status, and social class, no significant relationship of serum retinol and case status was found. In summary, these data fail to confirm the strong dose-response relationship between baseline retinol levels and subsequent cancer reported in the previous study.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6595454

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  Decreased levels of vitamin A in serum of patients with psoriasis.

Authors:  S Majewski; P Janik; A Langner; M Glinska-Ferenz; B Swietochowska; I Sawicki
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Serum retinol and risk of prostate cancer.

Authors:  Alison M Mondul; Joanne L Watters; Satu Männistö; Stephanie J Weinstein; Kirk Snyder; Jarmo Virtamo; Demetrius Albanes
Journal:  Am J Epidemiol       Date:  2011-03-09       Impact factor: 4.897

3.  Is serum selenium a risk factor for cancer?

Authors:  I Peleg; S Morris; C G Hames
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

4.  Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.

Authors:  Sarah H Nash; Cathee Till; Xiaoling Song; M Scott Lucia; Howard L Parnes; Ian M Thompson; Scott M Lippman; Elizabeth A Platz; Jeannette Schenk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-12       Impact factor: 4.254

5.  Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial.

Authors:  Susan Chadid; Xiaoling Song; Jeannette M Schenk; Bora Gurel; M Scott Lucia; Ian M Thompson; Marian L Neuhouser; Phyllis J Goodman; Howard L Parnes; Scott M Lippman; William G Nelson; Angelo M De Marzo; Elizabeth A Platz
Journal:  Nutr Cancer       Date:  2021-01-29       Impact factor: 2.900

6.  Serum retinol and subsequent risk of cancer.

Authors:  N Wald; J Boreham; A Bailey
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

7.  Cancer of the cervix uteri and vitamin A.

Authors:  R W Harris; D Forman; R Doll; M P Vessey; N J Wald
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

8.  Serum retinol level in patients with colorectal premalignant and malignant lesions.

Authors:  J Ostrowski; P Janik; M Nowacki; I Janczewska; M Przybyszewska; B Szaniawska; W Bartnik; E Butruk
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.